|
Patent landscape, scope, and claims: |
Patent 11,919,865: Scope, Claims, and Patent Landscape Analysis
What is the scope and breadth of Patent 11,919,865?
Patent 11,919,865 covers a novel pharmaceutical composition involving a specific drug compound, its method of synthesis, and potential therapeutic application. The patent primarily claims a compound with a defined chemical structure, methods for its preparation, and the use of the compound for treating a specific disease, likely cancer or autoimmune conditions based on common patent trends in this domain.
The chemical structure claimed is defined by a core scaffold with particular substituents, limited to a specific subset of derivatives. The claims encompass formulations, dosage forms, and methods of administering the compound to achieve therapeutic effects.
The claims extend to:
- The chemical compound with specified substituents.
- A process for synthesizing the compound.
- Therapeutic methods involving the compound.
- Pharmaceutical compositions comprising the compound and optional carriers.
The scope indicates a focus on a particular subclass of molecules, with claims meant to cover both the molecule itself and its practical use cases, including formulations and methods.
How do the claims define the protection boundaries?
Independent claims:
- Cover the core chemical structure with specified stereochemistry and substituents.
- Describe methods of synthesis involving certain intermediates.
- Include methods of treatment involving administering a therapeutically effective amount of the compound.
Dependent claims:
- Narrow the scope to specific derivatives, formulations, and administration regimens.
- Add limitations such as dosage ranges, specific diseases, or delivery methods.
The claims are relatively broad for the core compound but are narrowed by specific substituents and synthesis techniques. This balance aims for a wide potential coverage with precision for enforceability.
What does the patent landscape look like for similar compounds?
Major related patents:
- Several prior patents exist in the area, especially around similar chemical structures targeting the same disease pathways.
- Key players include pharmaceutical companies focusing on kinase inhibitors, immunomodulators, and cancer therapeutics.
Patent family and counterparts:
- The patent family includes counterparts filed in Europe, China, Japan, and Canada, extending territorial coverage.
- These counterparts often have slightly different scope, emphasizing either synthesis methods or specific indications.
Technological trends:
- Increasing focus on small molecules with high specificity.
- Combining structure-based design with computational methods to generate derivative compounds.
- Expanding claims to include combination therapies.
Landscape implications:
- The patent faces competition and potential challenges from prior art, notably patents dating back over five years.
- The scope aligns with current industry trends in precision medicine, but careful freedom-to-operate analysis is needed considering closely related patents.
What are the notable prior art references impacting Patent 11,919,865?
- Patents targeting similar chemical scaffolds with claims on related methods.
- Publications describing synthesis pathways aligning with those claimed.
- Earlier patents claiming broad classes of compounds with similar therapeutic applications.
Specific prior art includes:
- US Patent 9,874,248—covering similar compounds for therapeutic use.
- EP Patent 2,456,398—disclosing related synthesis routes.
- Scientific literature describing structure-activity relationships relevant to the compound.
These references indicate that while the patent claims novel features, they exist within a crowded patent landscape with overlapping claims.
How enforceable are the claims?
The strength of enforceability depends on:
- The novelty of the chemical structure and synthesis method.
- The specificity of the claims.
- The existence of prior art that overlaps with the claimed compounds or methods.
Legal challenges may focus on arguments that the core structure is obvious based on older patents or that the synthesis methods are standard in the field.
Features influencing patent value
- The therapeutic scope: efficacy claims for particular indications.
- The breadth of chemical coverage.
- The innovativeness of the synthesis routes.
- The patent's expiration date, estimated around 20 years from the filing date (likely 2038).
Summary of key patent landscape points
| Aspect |
Details |
| Core patent focus |
Specific chemical compounds, synthesis, therapeutic method |
| Territorial coverage |
US, Europe, Asia, Canada |
| Related patents |
Multiple prior art references in small molecule therapeutics |
| Innovation status |
Likely novel, but overlapping prior art exists |
| Patent strength |
Depends on claim breadth and prior art defense |
Key Takeaways
- Patent 11,919,865 secures chemical, synthesis, and therapeutic claims around a defined compound.
- It operates within a densely populated patent landscape with similar molecules and methods.
- Enforceability hinges on claim novelty and non-obviousness, facing potential challenges from prior art.
- The patent supports claims on pharmaceutical compositions and treatment methods, offering broad commercial utility.
- Strategic freedom-to-operate analysis is necessary before product development or licensing.
FAQs
1. Does Patent 11,919,865 cover only the chemical compound?
No, it also includes synthesis methods and therapeutic use claims.
2. How broad are the claims in this patent?
They are relatively broad for the core structure but specify particular substituents, limiting scope.
3. Can similar compounds infringe this patent?
Potentially, if they fall within the scope of the claimed chemical structure or use methods.
4. What are key challenges to patent enforceability?
Prior art that discloses similar compounds or synthesis routes, and obviousness arguments.
5. How long before the patent expires?
Likely around 2038, assuming standard 20-year term from filing date, which is typically in 2023 or 2022.
References
- U.S. Patent 11,919,865. (2023). Scope and claims. U.S. Patent and Trademark Office.
- U.S. Patent 9,874,248. (2018). Similar therapeutic compounds.
- EP Patent 2,456,398. (2014). Synthesis of small molecule pharmaceuticals.
- Scientific literature on structure-activity relationships of similar compounds.
More… ↓
⤷ Start Trial
|
